Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRWV NASDAQ:MDGL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRWVCoreWeave$88.88-0.9%$105.06$63.80▼$153.20$40.15B7.1728.43 million shs12.66 million shsMDGLMadrigal Pharmaceuticals$536.70-4.2%$511.48$286.44▼$615.00$12.91B-1.05407,285 shs294,013 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRWVCoreWeave-0.91%+8.72%-7.04%-12.86%-41.93%MDGLMadrigal Pharmaceuticals-4.16%+1.63%+13.87%+3.29%+73.92%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRWVCoreWeave$88.88-0.9%$105.06$63.80▼$153.20$40.15B7.1728.43 million shs12.66 million shsMDGLMadrigal Pharmaceuticals$536.70-4.2%$511.48$286.44▼$615.00$12.91B-1.05407,285 shs294,013 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRWVCoreWeave-0.91%+8.72%-7.04%-12.86%-41.93%MDGLMadrigal Pharmaceuticals-4.16%+1.63%+13.87%+3.29%+73.92%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRWVCoreWeave 2.54Moderate Buy$136.7353.83% UpsideMDGLMadrigal Pharmaceuticals 2.78Moderate Buy$687.9328.18% UpsideCurrent Analyst Ratings BreakdownLatest CRWV and MDGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/6/2026CRWVCoreWeave Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/2/2026CRWVCoreWeave Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$250.006/25/2026CRWVCoreWeave Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$250.006/24/2026CRWVCoreWeave Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/24/2026MDGLMadrigal Pharmaceuticals Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight6/24/2026CRWVCoreWeave Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy6/11/2026CRWVCoreWeave Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderperform6/11/2026CRWVCoreWeave Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$167.006/11/2026MDGLMadrigal Pharmaceuticals Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$550.00 ➝ $542.006/2/2026CRWVCoreWeave BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$192.006/2/2026CRWVCoreWeave BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$192.00(Data available from 7/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRWVCoreWeave$5.13B7.75$3.71 per share23.96$8.63 per share10.30MDGLMadrigal Pharmaceuticals$958.40M12.91N/AN/A$26.54 per share20.22Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRWVCoreWeave-$1.17B-$3.11N/AN/AN/A-25.57%-43.07%-3.84%N/AMDGLMadrigal Pharmaceuticals-$288.28M-$12.80N/A64.12N/A-27.32%-50.15%-25.44%8/4/2026 (Estimated)Latest CRWV and MDGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026MDGLMadrigal Pharmaceuticals-$2.7477N/AN/AN/A$349.80 millionN/A5/7/2026Q1 2026CRWVCoreWeave-$1.17-$1.40-$0.23-$1.40N/A$2.08 billion5/6/2026Q1 2026MDGLMadrigal Pharmaceuticals-$3.61-$3.25+$0.36-$3.25$301.05 million$311.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCRWVCoreWeaveN/AN/AN/AN/AN/AMDGLMadrigal PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRWVCoreWeave3.680.310.31MDGLMadrigal Pharmaceuticals0.633.503.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRWVCoreWeaveN/AMDGLMadrigal Pharmaceuticals98.50%Insider OwnershipCompanyInsider OwnershipCRWVCoreWeaveN/AMDGLMadrigal Pharmaceuticals17.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRWVCoreWeave2,189447.57 millionN/AN/AMDGLMadrigal Pharmaceuticals9023.06 million19.00 millionOptionableCRWV and MDGL HeadlinesRecent News About These CompaniesCandriam S.C.A. Increases Position in Madrigal Pharmaceuticals, Inc. $MDGL4 hours ago | marketbeat.comBofA lowers its Price Target on Madrigal Pharmaceuticals, Inc. (MDGL)July 8 at 4:11 PM | insidermonkey.comMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)July 6, 2026 | globenewswire.comMadrigal Pharmaceuticals, Inc. $MDGL Position Reduced by SG Americas Securities LLCJuly 4, 2026 | marketbeat.comRibo y Madrigal alcanzan un primer hito importante en el avance de nuevas terapias con siRNA para MASHJuly 2, 2026 | prnewswire.comRibo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASHJuly 1, 2026 | prnewswire.comMadrigal Pharmaceuticals (MDGL) Receives a Buy from JefferiesJuly 1, 2026 | theglobeandmail.comPictet Asset Management Holding SA Raises Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGLJune 29, 2026 | marketbeat.comAssenagon Asset Management S.A. Purchases 10,643 Shares of Madrigal Pharmaceuticals, Inc. $MDGLJune 29, 2026 | marketbeat.comMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)June 22, 2026 | globenewswire.comGroupama Asset Managment Boosts Stake in Madrigal Pharmaceuticals, Inc. $MDGLJune 19, 2026 | marketbeat.comJanus Henderson Group PLC Has $918.20 Million Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGLJune 18, 2026 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL is Armistice Capital LLC's 5th Largest PositionJune 18, 2026 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Polar Capital Holdings PlcJune 17, 2026 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Shares Sold by Avoro Capital Advisors LLCJune 17, 2026 | marketbeat.comAlkeon Capital Management LLC Acquires 120,000 Shares of Madrigal Pharmaceuticals, Inc. $MDGLJune 16, 2026 | marketbeat.comEntropy Technologies LP Increases Holdings in Madrigal Pharmaceuticals, Inc. $MDGLJune 15, 2026 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Stock Position Raised by Lord Abbett & CO. LLCJune 13, 2026 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Castleark Management LLCJune 13, 2026 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 10, 2026 | seekingalpha.comThe Bull Case For Madrigal Pharmaceuticals (MDGL) Could Change Following New Rezdiffra Cardiometabolic Data ReleaseJune 9, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026SpaceX Rings the Bell and Shatters Every RecordBy Jeffrey Neal Johnson | June 12, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026The Oil Trade May Not Be Over: 3 Energy Stocks to WatchBy Thomas Hughes | June 21, 2026CoreWeave Insider Sales Look Big, But Should Investors Worry?By Sam Quirke | June 17, 2026CRWV and MDGL Company DescriptionsCoreWeave NASDAQ:CRWV$88.88 -0.82 (-0.91%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$88.85 -0.03 (-0.03%) As of 07/10/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.Madrigal Pharmaceuticals NASDAQ:MDGL$536.70 -23.31 (-4.16%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$536.48 -0.22 (-0.04%) As of 07/10/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/06 - 07/10 Why WD-40 Is Proving Great Businesses Never Go Out of Style Rocket Lab’s Stock Drop Comes With a Bullish Twist Power Struggle: Wolfspeed Sues Navitas Over AI Chips Pushing the Edge: Super Micro Computer Reboots the AI Landscape Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
